Member Info for rp6577

FOMO is going to start kicking in real quick….. really not that long until January

Owned this stock a while back. Restarted a position today

Insider topping up at these levels. Always good to see

I think it’s driven by the very low volume. Just the smallest volume causes the price to move drastically. The financials look good, with revenue steadily increasing and they’re in an area (monoclonal antibodies) which is only going to see increasing demand

Topped up again :)

I topped up this morning. Valuation is tiny so looks like a great one to build up a position in

Some nice positive moment in the share price. I know you can’t put much weight in a price target but even anything near what they are saying means an incredible return from current prices. Hopefully they’ll announce some kind of non dilutive funding solution and we can get back on track

Definitely makes you feel more positive. Might see the share price to begin to recover a little from here

Ah thanks!

What platform can you buy them on? I can’t go HL

Tempted to pick up some shares at this level. Assuming a £9m 6 month cash burn rate, they still have a good 12 month cash runway. Phase 2 headline data due out towards the end of the year and they have started dosing on the pivotal phase 3 study. A £10m debt facility is probably all they need to get to a point where the share price will be significantly higher and an equity raise more palatable. Also a buyout potentially becomes more of a possibility at that point

Lots of buys coming in at 8p and below

A lot of small bios are valued at cash level or below. I don’t think Okyo has much cash so it is still relatively quite highly valued, which is why I think it is under pressure

Great update. Excited as we get through the summer and towards the end of the year. Expect some great SP appreciation as we lead up to the drilling

Doubled my position at 9.11 this morning. Not sure when it will skyrocket but I want a good ticket for the show

I’ve topped up my position. Tiny market cap and in area which has great growth potential

Cash burn is pretty much £20m a year. So they don’t have a huge amount of runway.

I’ve just started a position here and will build up over time

I feel very bullish after hearing the MS update. A wider trial that shows progressive MS is stopped in its tracks and also potentially improved, is massive. Also remember that is only one indication of Foralumab.

Agreed it has been a bit of a shambles in recent years, but this still has a good chance of being something really quite special

I think it’s our friend Sangi. He seemed to disappear just as this guy turned up

Part of me didn’t want HL to catch up…..

Painful reading but still bullish. I’ve not heard anything to say the science is not still on track (although granted slightly delayed timetable). The end game is still a potential game changer and could be massive.

Sitting tight and look forward to the March data on the MS patient